Ipratropium Bromide eent and Moxetumomab Pasudotox-tdfk
Determining the interaction of Ipratropium Bromide eent and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium nasal
Brand name: Atrovent Nasal
Synonyms: Ipratropium nasal, Ipratropium (Nasal)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ipratropium Bromide eent-Moxetumomab pasudotox-tdfk Intravenous
- Ipratropium Bromide eent-Moxifloxacin
- Ipratropium Bromide eent-Moxifloxacin (Systemic)
- Ipratropium Bromide eent-Moxifloxacin Hydrochloride
- Ipratropium Bromide eent-Moxifloxacin Injection
- Ipratropium Bromide eent-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Ipratropium Bromide Nebuamp
- Moxetumomab Pasudotox-tdfk-Ipratropium inhalation
- Moxetumomab Pasudotox-tdfk-Ipratropium Inhalation Aerosol
- Moxetumomab Pasudotox-tdfk-Ipratropium Inhalation Solution
- Moxetumomab Pasudotox-tdfk-Ipratropium Inhalation, oral/nebulization
- Moxetumomab Pasudotox-tdfk-Ipratropium nasal